Research Article| Volume 312, ISSUE 1-2, P92-96, January 15, 2012

Download started.


CCG polymorphisms in the huntingtin gene have no effect on the pathogenesis of patients with Huntington's disease in mainland Chinese families

Published:August 29, 2011DOI:


      Huntington's disease (HD) is caused by the abnormal expansion of CAG repeats in the huntingtin gene (HTT). The adjacent proline-rich region, which also has a CCG polymorphism among people of different races, may also affect the pathogenesis of HD. To study the effect of this polymorphism on patients with HD in mainland China, 53 HD mutant alleles were examined. The results showed that 54.72% of the HD mutant alleles had 10-repeat alleles, and the remaining 45.28% had 7-repeat alleles. Moreover, comparison of the clinical features between the two groups revealed no significant difference. We also investigated its effect on the aggregates in vitro. No significant difference was detected when the morphology and size of the aggregates with the two polymorphisms was compared in cells. Given these findings, it was quite reasonable to suppose that the CCG polymorphism may not influence the pathogenesis of patients with HD in mainland China.


      HD (Huntington's disease), polyQ (polyglutamine), htt (huntingtin(protein)), HTT (huntingtin(gene)), HEK293T (human embryonic kidney 293T cells), PCR (polymerase chain reaction), GFP (green fluorescent protein), DMEM (Dulbecco's modified Eagle's medium), FBS (fetal bovine serum), DAPI 4′ (6-diamidino-2-phenylindole)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Li S.H.
        • Li X.J.
        Huntingtin and its role in neuronal degeneration.
        Neuroscientist. 2004; 10: 467-475
        • The Huntington's Disease Collaborative Research Group
        A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.
        Cell. 1993; 72: 971-983
        • Rubinsztein D.C.
        • Leggo J.
        • Chiano M.
        • Dodge A.
        • Norbury G.
        • Rosser E.
        • et al.
        Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease.
        Proc Natl Acad Sci U S A. 1997; 94: 3872-3876
        • Metzger S.
        • Bauer P.
        • Tomiuk J.
        • Laccone F.
        • Didonato S.
        • Gellera C.
        • et al.
        The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.
        Neurogenetics. 2006; 7: 27-30
        • Squitier F.
        • Andrew S.E.
        • Goldberg Y.P.
        • Kremer B.
        • Spence N.
        • Zeisler J.
        • et al.
        DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence.
        Hum Mol Genet. 1994; 3: 2103-2114
        • Almqvist E.
        • Spence N.
        • Nichol K.
        • Andrew S.E.
        • Vesa J.
        • Peltonen L.
        • et al.
        Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease.
        Hum Mol Genet. 1995; 4: 207-214
        • Morovvati S.
        • Nakagawa M.
        • Osame M.
        • Karami A.
        Analysis of CCG repeats in Huntingtin gene among HD patients and normal populations in Japan.
        Arch Med Res. 2008; 39: 131-133
        • Rockabrand E.
        • Slepko N.
        • Pantalone A.
        • Nukala V.N.
        • Kazantsev A.
        • Marsh J.L.
        • et al.
        The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis.
        Hum Mol Genet. 2007; 16: 61-77
        • Steffan J.S.
        • Agrawal N.
        • Pallos J.
        • Rockabrand E.
        • Trotman L.C.
        • Slepko N.
        • et al.
        SUMO modification of Huntingtin and Huntington's disease pathology.
        Science. 2004; 304: 100-104
        • Read A.P.
        Huntington's disease: testing the test.
        Nat Genet. 1993; 4: 329-330
        • Snell R.G.
        • MacMillan J.C.
        • Cheadle J.P.
        • Fenton I.
        • Lazarou L.P.
        • Davies P.
        • et al.
        Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.
        Nat Genet. 1993; 4: 393-397
        • Sambrook J.
        • Russell D.W.
        Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY)2001: 463-471
        • Masuda N.
        • Goto J.
        • Murayama N.
        • Watanabe M.
        • Kondo I.
        • Kanazawa I.
        Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.
        J Med Genet. 1995; 32: 701-705
        • Wang C.K.
        • Wu Y.R.
        • Hwu W.L.
        • Chen C.M.
        • Ro L.S.
        • Chen S.T.
        • et al.
        DNA haplotype analysis of CAG repeat in Taiwanese Huntington's disease patients.
        Eur Neurol. 2004; 52: 96-100
        • Rubinsztein D.C.
        • Barton D.E.
        • Davison B.C.
        • Ferguson-Smith M.A.
        Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat number.
        Hum Mol Genet. 1993; 2: 1713-1715
        • Vuillaume I.
        • Vermersch P.
        • Destée A.
        • Petit H.
        • Sablonnière B.
        Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease.
        J Neurol Neurosurg Psychiatry. 1998; 64: 758-762
        • Myrianthopoulos N.C.
        Huntington's chorea.
        J Med Genet. 1966; 3: 298-314
        • Oliver J.
        • Dewhurst K.
        Childhood and adolescent forms of Huntington's disease.
        J Neurol Neurosurg Psychiatry. 1969; 32: 455-459
        • Behan P.O.
        • Bone I.
        Hereditary chorea without dementia.
        J Neurol Neurosurg Psychiatry. 1977; 40: 687-691
        • Rosenberg N.K.
        • Sørensen S.A.
        • Christensen A.L.
        Neuropsychological characteristics of Huntington's disease carriers: a double blind study.
        J Med Genet. 1995; 32: 600-604
        • Bhattacharyya A.
        • Thakur A.K.
        • Chellgren V.M.
        • Thiagarajan G.
        • Williams A.D.
        • Chellgren B.W.
        • et al.
        Oligoproline effects on polyglutamine conformation and aggregation.
        J Mol Biol. 2006; 355: 524-535
        • Dehay B.
        • Bertolotti A.
        Critical role of the proline-rich region in Huntingtin for aggregation and cytotoxicity in yeast.
        J Biol Chem. 2006; 281: 35608-35615